Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -5.00 (-2.20%)
Bid:
222.00
Ask:
232.00
Spread: 10.00 (4.505%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Microgen Aptitude Modules Launch

15 Sep 2010 07:00

RNS Number : 6850S
Microgen PLC
15 September 2010
 



microgen

www.microgen.com

 

15 September 2010

 

 

 

MICROGEN LAUNCHES THREE NEW MICROGEN APTITUDE SOFTWARE MODULES

 

Microgen plc (Microgen' or 'the Group') today launches three new modules for its flagship Business Process Platform, Microgen Aptitude. The new modules provide substantial performance improvements on the already market-leading capability of Microgen Aptitude and maintain Microgen's position as the technology leader in this category. The modules build on the performance and functionality of Microgen Aptitude Version 3.0, introduced in June 2010.

 

The new Microgen Aptitude Version 3.0 Modules are:

 

Microgen Aptitude DBClarity - This new capability within Microgen Aptitude functionality positions Microgen at the forefront of the emerging technology of in-database analytics, providing substantial performance improvements to database-intensive applications. Through its graphical interface, Microgen Aptitude DBClarity addresses one of the major functional weaknesses of current in-database analytics which are written in the database language resulting in a lack of transparency and auditability for non-programmers. For the first time, a business will be able to address this weakness and develop high performance in-database analytical applications via a graphical interface thereby reducing operational risk, speeding up the analysis process and improving collaboration between the business and IT.

 

Microgen Aptitude PerformancePLUS - Building on the market leading performance of Microgen Aptitude Version 3.0, the Microgen Aptitude PerformancePLUS module delivers transaction processing speeds that are up to a further 30 per cent faster. Such speeds are critical in high-volume and complex transaction environments such as digital media and retail banking. This performance improvement is achieved by, amongst other leading edge developments, the adoption of Microgen's innovative fast enrichment process, for which a patent has been filed making a total of 12 patents now filed associated with the Microgen Aptitude technology.

 

Microgen Aptitude BPD & SOA Orchestration - This module enables SOA orchestration from entities within the Business Process Diagram (BPD) providing the ability to merge new and old technologies, such as the integration of cloud services with legacy systems to create an agile environment that can respond rapidly to the speed of business change. With Microgen Aptitude BPD & SOA Orchestration, both IT and business users can now build and deploy flexible applications quickly within a Service Orientated Architecture (SOA) environment.

 

These new modules for Microgen Aptitude maintain Microgen's technology leadership position at the forefront of high volume processing in complex transaction environments. Microgen's market-leading capability has been further extended in terms of both performance and functionality. Furthermore, in-database analytics are increasingly being adopted as a necessary development to increase performance of database-intensive applications and Microgen has addressed one of the major limitations of current market solutions.

 

Contacts

Martyn Ratcliffe, Chairman 01252-772300

David Sherriff, Chief Operating Officer

Philip Wood, Group Finance Director

 

James Melville-Ross, Financial Dynamics 020-7831-3113

Haya Herbert-Burns, Financial Dynamics

 

Copyright © 2010 Microgen plc All Rights Reserved Microgen ® Microgen plc Microgen Aptitude ® Microgen Aptitude Limited Microgen Aptitude - Patent Pending (Serial No: 1686466) & U.S. Patents Pending

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLLLFLRALISLII
Date   Source Headline
17th Apr 202311:49 amRNSHolding(s) in Company
17th Apr 20238:32 amRNSHolding(s) in Company
29th Mar 20234:36 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
29th Mar 202311:27 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
13th Feb 20235:20 pmRNSHolding(s) in Company
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20237:00 amRNSFull Year Trading Update and Directorate Change
12th Jan 20239:51 amRNSNew Directorship Notification
24th Nov 20227:00 amRNSGrant of awards under Performance Share Plan
8th Nov 20227:00 amRNSGrant of awards
21st Oct 20224:41 pmRNSSecond Price Monitoring Extn
21st Oct 20224:36 pmRNSPrice Monitoring Extension
28th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Jul 20227:00 amRNSInterim Results
18th Jul 20227:00 amRNSNotice of Results
31st May 202211:40 amRNSTotal Voting Rights
26th May 20228:56 amRNSHolding(s) in Company
17th May 20221:57 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20222:10 pmRNSDirector Shareholding
29th Apr 202210:56 amRNSTotal Voting Rights
28th Apr 202212:24 pmRNSResult of AGM and Directorate Change
28th Apr 20227:00 amRNSAGM Statement
12th Apr 202211:50 amRNSBlock Listing Application
11th Apr 20222:30 pmRNSBlock listing Interim Review
4th Apr 20227:00 amRNSGrant of awards under 2020 Deferred Bonus Plan
22nd Mar 20227:00 amRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSAudited Preliminary Results
1st Mar 20221:00 pmRNSTotal Voting Rights
1st Feb 202211:05 amRNSTotal Voting Rights
20th Jan 20227:00 amRNSTrading Update and Notice of Results
1st Dec 20217:00 amRNSTotal Voting Rights
8th Nov 20215:05 pmRNSGrant of awards under Performance Share Plan
1st Nov 20214:50 pmRNSTotal Voting Rights
25th Oct 20217:00 amRNSBlock Listing Application
11th Oct 20217:00 amRNSAcquisition of MPP Global Solutions Limited
1st Oct 20217:00 amRNSNon-Executive Directorate and Committee Changes
28th Sep 202111:24 amRNSBlock listing Interim Review
17th Sep 20217:00 amRNSChange of Auditor
28th Jul 20217:00 amRNSInterim Results
16th Jul 20217:00 amRNSNotice of Results
6th Jul 202110:39 amRNSHolding(s) in Company
1st Jul 20217:00 amRNSTotal Voting Rights
15th Jun 20219:57 amRNSDirector Declaration
27th May 20218:20 amRNSDirector Declaration
6th May 20213:36 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20213:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.